WHX 2026
Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.
Dubai, UAE
Vermon is proud to announce that it has been awarded the EcoVadis Gold Medal 2025 for the second consecutive year, recognizing the strength, consistency and maturity of its Corporate Social Responsibility (CSR) strategy.
Awarded by EcoVadis, a global reference in sustainability assessments, this distinction places Vermon among the top 5% of companies worldwide evaluated on environmental, social, ethical and responsible procurement criteria.
Vermon’s CSR approach is built around four complementary pillars that are fully integrated into its operations and governance.
Being a “Good Place to Work”
Employee well-being, safety and inclusion are central to Vermon’s social commitments. In 2024, 100% of new employees received safety training, and the company maintained a high professional gender equality index of 93/100. Vermon also promotes long-term employment, with over 97% of employees on permanent contracts, reflecting a stable and engaging work environment.
Developing ethical and sustainable business practices
Ethics and responsibility guide Vermon’s business conduct and supplier relationships. Responsible purchasing criteria are increasingly embedded across the supply chain. In parallel, the majority of strategic suppliers are now assessed on CSR criteria, reinforcing transparency and continuous improvement.
Contributing to better healthcare for all
Innovation is at the core of Vermon’s contribution to health and safety. The company actively collaborates with research centers, hospitals and industrial partners, participating in multiple collaborative projects and producing a growing number of scientific publications each year. These efforts support the development of more reliable diagnostic solutions that benefit both patients and healthcare professionals.
Reducing our environmental footprint
Vermon continues to reduce the environmental impact of its industrial activities through ongoing optimization initiatives. Over the past few years, energy consumption per unit produced has decreased significantly, while water usage and waste management practices have been progressively improved. These results are supported by certified environmental management systems and targeted investments in more efficient technologies.
The EcoVadis Gold Medal reflects measurable progress across all four pillars, including:
Receiving the EcoVadis Gold Medal for the second year in a row is above all a collective achievement, driven by the daily commitment of Vermon’s teams. It illustrates the company’s determination to align industrial performance with responsibility, integrity and long-term value creation.
This recognition is not an end in itself, but a strong incentive to continue improving, innovating responsibly and contributing to a more sustainable future for our industry.
WHX 2026
Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.
Dubai, UAE
Read More
Vermon Wins the INPI Export Award 2025 for Innovation and Intellectual Property
Vermon has been awarded the INPI Export Award 2025, recognizing the strength of our intellectual property strategy and its role in supporting the international development of our high-performance ultrasound technologies. This distinction highlights Vermon’s contribution to French medical innovation and its global impact in the field of medical ultrasound and diagnostic imaging.
Read More
Multidisciplinary Group Awarded in France 2030 Plan to Develop Next-Generation Software-Based, Smart, and Frugal Ultrasound Imaging Devices
The POCUSI (Point of Care UltraSound for Screening & Intervention) consortium—bringing together E-Scopics, Vermon, IHU Strasbourg, and Inria—has been awarded funding under the France 2030 investment plan to develop a new generation of software-based, intelligent, and frugal ultrasound imaging devices.
With a total budget of €6.7 million over five years, the project aims to democratize point-of-care ultrasound, making advanced imaging accessible to non-expert operators throughout the patient care pathway. POCUSI focuses particularly on chronic liver diseases and metabolic disorders, enabling improved screening, monitoring, and image-guided interventions. By combining cutting-edge software, high-performance probes, clinical expertise, and data-driven simulation tools, POCUSI supports the emergence of a strategic and sustainable French digital ultrasound sector, strengthening France’s technological sovereignty in medical imaging.
Read More
RSNA 2025
Join Vermon at RSNA 2025 in Chicago, USA, from November 30 to December 4. Discover our latest ultrasound transducer innovations and meet our team in North Hall, Level 3 – Booth 8049.
CHICAGO, USA
Read More
MEDICA 2025
The world of medical technology meets again at MEDICA 2025! Visit Vermon in Hall 9, Booth 17, to explore our latest ultrasound innovations and learn how we’re advancing diagnostic imaging for better patient care.
DÜSSELDORF, GERMANY
Read More